Your browser doesn't support javascript.
loading
REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival.
Song, Kwon-Ho; Woo, Seon Rang; Chung, Joon-Yong; Lee, Hyo-Jung; Oh, Se Jin; Hong, Soon-Oh; Shim, Jaegal; Kim, Yong Nyun; Rho, Seung Bae; Hong, Seung-Mo; Cho, Hanbyoul; Hibi, Masahiko; Bae, Dong-Jun; Kim, Sang-Yeob; Kim, Min Gyu; Kim, Tae Woo; Bae, Young-Ki.
Afiliação
  • Song KH; Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Republic of Korea.
  • Woo SR; Department of Biochemistry, Korea University College of Medicine, Seoul, Republic of Korea.
  • Chung JY; Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
  • Lee HJ; Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Republic of Korea.
  • Oh SJ; Department of Biochemistry, Korea University College of Medicine, Seoul, Republic of Korea.
  • Hong SO; Translational Research Institute for Incurable Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Shim J; Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Kim YN; Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Republic of Korea.
  • Rho SB; Department of Biochemistry, Korea University College of Medicine, Seoul, Republic of Korea.
  • Hong SM; Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
  • Cho H; Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Republic of Korea.
  • Hibi M; Department of Biochemistry, Korea University College of Medicine, Seoul, Republic of Korea.
  • Bae DJ; Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
  • Kim SY; Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Republic of Korea.
  • Kim MG; Department of Biochemistry, Korea University College of Medicine, Seoul, Republic of Korea.
  • Kim TW; Department of Biomedical Sciences, College of Medicine, Korea University, Seoul, Republic of Korea.
  • Bae YK; Comparative Biomedicine Research Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.
Cell Death Dis ; 8(1): e2536, 2017 01 05.
Article em En | MEDLINE | ID: mdl-28055019
ABSTRACT
Rab escort protein 1 (REP1) is a component of Rab geranyl-geranyl transferase 2 complex. Mutations in REP1 cause a disease called choroideremia (CHM), which is an X-linked eye disease. Although it is postulated that REP1 has functions in cell survival or death of various tissues in addition to the eye, how REP1 functions in normal and cancer cells remains to be elucidated. Here, we demonstrated that REP1 is required for the survival of intestinal cells in addition to eyes or a variety of cells in zebrafish, and also has important roles in tumorigenesis. Notably, REP1 is highly expressed in colon cancer tissues and cell lines, and silencing of REP1 sensitizes colon cancer cells to serum starvation- and 5-FU-induced apoptosis. In an effort to elucidate the molecular mechanisms underlying REP1-mediated cell survival under those stress conditions, we identified FOXO3 as a binding partner of REP1 using a yeast two-hybrid (Y2H) assay system, and we demonstrated that REP1 blocked the nuclear trans-localization of FOXO3 through physically interacting with FOXO3, thereby suppressing FOXO3-mediated apoptosis. Importantly, the inhibition of REP1 combined with 5-FU treatment could lead to significant retarded tumor growth in a xenograft tumor model of human cancer cells. Thus, our results suggest that REP1 could be a new therapeutic target in combination treatment for colon cancer patients.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Proteínas Adaptadoras de Transdução de Sinal / Carcinogênese / Proteína Forkhead Box O3 Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Proteínas Adaptadoras de Transdução de Sinal / Carcinogênese / Proteína Forkhead Box O3 Idioma: En Ano de publicação: 2017 Tipo de documento: Article